Health Data Works

Investor Relations

Transforming Cannulation Through Real-Time Clinical Decision Support

At Health Data Works, we are building the future of dialysis access management through intelligent software and applied machine learning.

Our flagship platform, Veristra™, has received FDA Breakthrough Device Designation, is FDA-registered as a Class I medical device, and is currently undergoing pilot implementation across multiple dialysis centers.

Intelligent Healthcare Data Solutions with Veristra™

With over 7,500 dialysis clinics in the U.S. and millions of patients globally, vascular access management represents a critical — and historically underserved — opportunity for clinical innovation and cost savings.

Veristra™ introduces real-time visualization, standardized training, and predictive insights that may Improve care quality, extend graft life, and reduce costly complications.

Veristra Branding 2025
Copy of Logo Horizontal bluer

Health Data Works is currently advancing toward commercialization in both U.S. and international markets.

We offer an attractive, capital-efficient SaaS model with long-term data value potential. Our leadership team includes experienced clinicians, technologists, and healthcare entrepreneurs committed to impact and scale.

We welcome inquiries from qualified investors who share our vision of transforming dialysis care and improving outcomes for patients worldwide.

Interested? Learn more about current funding rounds or investor materials